Hudson Bay Capital Management’s Verona Pharma VRNA Stock Holding History

Hudson Bay Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-455,334	Closed	-$48.6M	–	1546
2025 Q3	$48.6M	Buy	+455,334	New	+$47.5M	0.16%	104
2025 Q1	–	Sell	-43,500	Closed	-$2.02M	–	1475
2024 Q4	$2.02M	Buy	+43,500	New	+$1.63M	0.01%	659

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Hudson Bay Capital Management's VRNA Position: Q4 2025 in Review

Hudson Bay Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 455,334 shares — an estimated $48.6M sold.

Hudson Bay Capital Management first reported a position in VRNA in Q4 2024 and held it in 2 quarters. The position peaked at $48.6M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Hudson Bay Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Hudson Bay Capital Management sold 455,334 Verona Pharma shares in Q4 2025, an estimated $48.6M.
Hudson Bay Capital Management first reported a position in Verona Pharma in Q4 2024 and held it in 2 quarters.
Hudson Bay Capital Management's Verona Pharma position peaked at $48.6M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Hudson Bay Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.